Latest "StateServ Holdings and Hospicelink" News Stories

02:10 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "StateServ Holdings and Hospicelink" found in our extensive news archives from over 250 global news sources.

More Information about StateServ Holdings and Hospicelink on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about StateServ Holdings and Hospicelink for you to read. Along with our medical data and news we also list StateServ Holdings and Hospicelink Clinical Trials, which are updated daily. BioPortfolio also has a large database of StateServ Holdings and Hospicelink Companies for you to search.

Showing "StateServ Holdings Hospicelink" News Articles 1–25 of 1,600+

Monday 18th February 2019

Guangzhou Pharmaceutical Holdings Limited(GPHL): Gourd Culture of GPHL: Take Gourd as Symbol to Heal People

GUANGZHOU, CHINA / ACCESSWIRE / February 18, 2019 / Abstract: "What is a gourd? Some will say that it is a tool to draw water, some regard it as a totem of good luck, and some others may think it i...

Global Sugar Substitutes Market Research Report 20122024 [Report Updated: 01011970] Prices from USD $2050

The global Sugar Substitutes market will reach Volume Million USD in 2017 with CAGR xx% 20192023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describes major p...

Friday 15th February 2019

TransCanna Announces Corporate Update Conference Call

Vancouver, British Columbia--(Newsfile Corp. - February 15, 2019) - TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") intends to host a corporate update conference cal...

The Biotech Growth Trust (BIOG) - Industry backdrop remains favourable

Edison Investment Research - Investment trusts - The Biotech Growth Trust: The Biotech Growth Trust (BIOG) is managed by Geoff Hsu and Richard Klemm at OrbiMed Capital, one of the leading global healthcare asset managers. The year 2018 proved to be tough for the trust’s performance as biotech companies delivering negative news were heavily penalised, while those delivering good news went unr...

Deutsche Beteiligungs (DBAN) - Market sentiment weighing on portfolio value

Edison Investment Research - Investment trusts - Deutsche Beteiligungs: Deutsche Beteiligungs (DBAG) is making steady progress on its investment agenda, with three new acquisitions and several follow-on funding rounds totalling €40.2m completed in Q119. DBAG’s Fund VII has so far been able to allocate 56% of its investment commitments in seven transactions, reflecting solid portfolio r...

Rallye bei Aphria: Aktie gewinnt mehr 7%: Sonderausschuss mit positivem Resultat - auch Aurora und Canopy deutlich im Plus

Nun ist er da: Der Bericht des unabhängigen Sonderausschusses, den Aphria beauftragt hat, um die gegen das Unternehmen erhobenen Vorwürfe im Zusammenhang mit der Übernahme von LATAM Holdings zu unt...

FDA accelerates review of Fujirebio's Alzheimer's test

Miraca Holdings subsidiary Fujirebio Diagnostics' Lumipulse G β-Amyloid Ratio quantitative in vitro diagnostic test for Alzhe -More- 

IRW-News: TransCanna Holdings Inc.: The Green Scene Podcast: Berichterstattung über das wichtige Update der TransCanna-Akquisition

IRW-PRESS: TransCanna Holdings Inc.: The Green Scene Podcast: Berichterstattung über das wichtige Update der TransCanna-Akquisition The Green Scene Podcast: Berichterstattung über das wichtige Upd...

Patisserie Valerie parent Patisserie Holdings sells Baker & Spice chain for £2.5mln

The deal with the Department of Coffee & Social Affairs follows news yesterday that the Patisserie Valerie chain itself had been sold to Irish private equity firm Causeway Capital

Thursday 14th February 2019

Senseonics Announces Partnership with Geo-Med to Provide Veterans Access to Eversense CGM

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today has announced that it has partnered with Geo-Med, LLC, a verified Service-Disabled Veteran-Owned Small Business (SDVOSB) to prov...

IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q4 2018 Results - Earnings Call Transcript

CORRECTING and REPLACING Fujirebio Diagnostics Receives FDA Breakthrough Device Designation for Lumipulse® G β-Amyloid Ratio (1-42/1-40) Quantitative In Vitro Diagnostic Test

The date in the first paragraph, first sentence of release should read: February 1, 2019 (instead of January 3, 2019). The website in the fifth paragraph, last sentence should read (instead of This press release features multimedia. View the full release here:

Adult and Pediatric Hemoconcentrators Market to Surpass US$ 14.3 Million by 2026 – Coherent Market Insights

According to Coherent Market Insights, the adult and pediatric hemoconcentrators market was valued at US$ 10.7 million in 2017, and is projected to exhibit a CAGR of 3.3% over the forecast period (2018–2026). Key Trends and Analysis of the Adult and Pediatric Hemoconcentrators Market: A hemoconcentrator is a device used for removal of e...

Cheetah Medical Partners with SWK Funding LLC to Advance Commercial Operations

Cheetah Medical, Inc., a Massachusetts-based leader in non-invasive fluid management devices, today announced it has entered into a $20 million senior secured term loan agreement with SWK Funding LLC. SWK Funding LLC is a subsidiary of SWK Holdings Corporation, a Dallas, Texas-based healthcare focused investment firm. Cheetah will use the ...

TILT Holdings Reports Preliminary Consolidated Revenue for January 2019 and Fiscal Year 2018

TILT Holdings Inc. ("TILT" or the “Company”) (CSE: TILT) (OTC: SVVTF) today announced preliminary and unaudited pro forma January 2019 gross revenue of US$18.3 million(1). This compares favorably to the Company’s unaudited pro forma 2018 annual gross revenue of US$97.3 million(2). Gross margins for January were 16% given the early st...

Fujirebio Diagnostics Receives FDA Breakthrough Device Designation for Lumipulse® G β-Amyloid Ratio (1-42/1-40) Quantitative In Vitro Diagnostic Test

Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received Breakthrough Device Designation (formerly known as Expedited Access Pathway (EAP) designation) from the Center of Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) on January 3, 2019 for the Lumipulse G β-Amyloid Ratio (1-42/1-4...

IQVIA Reports Fourth-Quarter and Full-Year 2018 Results, Issues First-Quarter and Full-Year 2019 Guidance

Revenue of $2,688 million for the fourth quarter and $10,412 million for the full year Adjusted EBITDA of $583 million for the fourth quarter and $2,224 million for the full year GAAP Diluted Earnings per Share of $0.34 for the fourth quarter and $1.24 for the full year Adjusted Diluted Ear...

IQVIA Holdings, Inc. 2018 Q4 - Results - Earnings Call Slides

This Day That Year: Motus GI Holdings

Shares of Motus GI Holdings Inc. (MOTS) are down nearly 60% from their 52-week high of $10.66 recorded on July 9, 2018.

Wednesday 13th February 2019

CannTrust Adds to Leadership Team With Appointment of Greg Guyatt as CFO

Ian Abramowitz to Lead Global Investments and Partnerships VAUGHAN, Ontario, Feb. 13, 2019 /PRNewswire/ -- CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX: TRST) is pleased to announce...

Demands for BPU Holdings Shares Grow as Stakeholders Hit 6,000 Mark

BPU Holdings, an Artificial Emotional Intelligence Company, Has Surpassed a 6,000 Shareholder Benchmark in the New Year Pioneer of Artificial Emotional Intelligence (AEI), BPU Holdings (BPU) had another successful year as the demand for its shares grows, hitting the 6,000 stakeholders mark in just the span of a year. Founded in 2012, BPU has b...

OrganiGram Holdings: Wird es dieses Mal etwas?

Mit großen Ambitionen jagte die Aktie Ende Januar in Richtung der alten Hochs aus dem Jahr 2018 und damit in Richtung zentraler Widerstandszone. Die Aktie profitierte zum einen von der deutlich ver...

MMJ Files FDA Fast Track Approval Application For Cannabis Multiple Sclerosis Drug

FDA grants Fast Track Designation to help expedite the review and approval of drugs in development that treat serious or life threatening diseases and fill an unmet medical need. MMJ International Holdings will be one of the world’s first natural plant-derived cannabinoid prescription drugs once approved by the FDA for the treatment of spasticity and pain due to multiple sclerosis. RESTON, Va. (...

Tuesday 12th February 2019

Series E brings $79mm to Nuvaira

Nuvaira Inc. (formerly Holaira; medical devices to treat obstructive lung diseases) raised $79mm in its Series E financing le...

Myomo, Inc. Announces Closing of Public Offering and Full Exercise of Over-Allotment Option

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today has closed its previously announced underwritten public offering of 3,950,000 shares of common stock at an offering price of $1.40 per sh...

Quick Search


News Quicklinks